UnitedHealth Group recently underwent a flurry of analyst re-evaluations, most involving lowered price targets and a few ...

Cambridge Investment Research Advisors Inc. slightly trimmed its Exxon Mobil holdings in Q4, selling off a modest 0.6% stake, ...

Renaissance Technologies slashed its Mastercard stake by 98.6%, leaving it with a petite 384 shares worth $204,000—because ...

Cambridge Investment Research Advisors upped its stake in Home Depot by 2.2%, snagging over 5,000 extra shares for a total ...

Warren Buffett is stepping down as CEO of Berkshire Hathaway at the end of 2025, marking the end of a legendary era. He ...

Oracle has launched two new cloud services aimed at streamlining retail banking operations, targeting lending and collections ...

AbbVie’s stock faced a chilly reception on May 6, plunging 4.55% and ending the day at $187.15. Despite strong fundamentals ...

Hedge funds are bullish on Salesforce thanks to its strategic dive into AI, fintech-friendly vibes, and clever acquisitions.

Merck's stock is acting like it drank three espressos—its implied volatility has hit 32.3%, the highest in a year. This opens ...

Roth Capital adjusted AMD’s price target downward from $140 to $125 but kept its “Buy” rating firmly intact. Despite ...

Cary Street Partners Financial LLC snagged 122,937 Bank of America shares in Q4, dropping $5.4 million like it’s spare change ...

Cambridge Investment Research Advisors increased its Chevron holdings by 11,290 shares during the fourth quarter, now owning ...